-
Zacks #1 Rank Additions for Tuesday - Tale of the Tape
Tuesday, December 21, 2010 - 9:14am | 339Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today: 51job Inc (JOBS) Aar Corp (AIR) Banco Bradesco (BBD) Buckeye Tech (BKI) Caliper Life Sciences (CALP) View the entire Zacks #1 Rank List. AAR CORP (AIR): Free Stock Analysis Report BANCO BRADESCO (BBD): Free Stock Analysis...
-
ERT Appoints Joel Morganroth, MD as Interim CEO
Tuesday, December 21, 2010 - 8:12am | 33ERT (Nasdaq: ERES) today confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is December 21, 2010.
-
Medivation Up Nearly 6% (MDVN)
Monday, December 20, 2010 - 4:59pm | 68Medivation, Inc. (NASDAQ: MDVN) is having a great day today, trading up nearly 6% on the back of strong, heavy volume. It's traded almost 850,000 shares, which is more than three times its average daily volume. Medivation, Inc., a biopharmaceutical company, focuses on the development of small...
-
Sanofi Expands Oncology Pipeline - Analyst Blog
Monday, December 20, 2010 - 3:00pm | 620French pharma giant Sanofi-Aventis (SNY) recently entered into two agreements in order to bolster its oncology franchise. While the first agreement was signed with Avila Therapeutics, the second was signed with Merck KGaA (MKGAF). Avila Deal Under the first agreement, which is initially for...
-
Bioanalytical Systems Up 23.6% After Hitting 52-Week High (BASI)
Monday, December 20, 2010 - 2:42pm | 146Shares of Bioanalytical Systems, Inc. (Nasdaq: BASI) are trading up 23.6% at $3.30 per share during the Monday afternoon trading session. The day's trading range for shares of Bioanalytical Systems, Inc has been between $2.96 and a 52-week high of $3.98 per share. Trading volume for Bioanalytical...
-
Sanofi Expands Oncology Pipeline - Analyst Blog
Monday, December 20, 2010 - 2:36pm | 620French pharma giant Sanofi-Aventis (SNY) recently entered into two agreements in order to bolster its oncology franchise. While the first agreement was signed with Avila Therapeutics, the second was signed with Merck KGaA (MKGAF). Avila Deal Under the first agreement, which is initially for...
-
NASDAQ Stocks Hitting 52-Week Highs (ORIT, BASI, APSG, HELE)
Monday, December 20, 2010 - 11:28am | 166Oritani Financial Corp (NASDAQ: ORIT) shares gained 1.76% to create a new 52-week high of $12.16. ORIT's trailing-twelve-month operating margin is 32.76%. Bioanalytical Systems Inc (NASDAQ: BASI) shares jumped 31.08% to touch a new 52-week high of $3.50. BASI's shares have surged 144.95% over the...
-
Morning Market Movers (BASI, WH, VPF, PZG)
Monday, December 20, 2010 - 11:05am | 144Bioanalytical Systems Inc (NASDAQ: BASI) jumped 30.33% to $3.48 at 10:00 am. BASI's shares have surged 144.95% over the past 52 weeks, while the S&P 500 index has gained 12.83% in the same period. WSP Holdings Limited (NYSE: WH) climbed 25.96% to $1.31. WH has received new orders worth $91.8...
-
Regulatory Setback for AstraZeneca - Analyst Blog
Friday, December 17, 2010 - 8:03pm | 490AstraZeneca (AZN) recently suffered a major setback with the US Food and Drug Administration (FDA) issuing a complete response letter (CRL) for Brilinta (ticagrelor). The company was seeking approval for the use of Brilinta in the treatment of acute coronary syndrome (ACS). The agency has asked...
-
Regulatory Setback for AstraZeneca - Analyst Blog
Friday, December 17, 2010 - 7:21pm | 490AstraZeneca (AZN) recently suffered a major setback with the US Food and Drug Administration (FDA) issuing a complete response letter (CRL) for Brilinta (ticagrelor). The company was seeking approval for the use of Brilinta in the treatment of acute coronary syndrome (ACS). The agency has asked...
-
Charles River's Business Outlook - Analyst Blog
Friday, December 17, 2010 - 7:03pm | 813Charles River Laboratories (CRL) recently discussed its business outlook with investors and clarified its focus on four key initiatives to drive shareholder value. The company also announced 2011 guidance and made some changes to its 2010 outlook. The four key initiatives are as follows:...
-
Charles River's Business Outlook - Analyst Blog
Friday, December 17, 2010 - 6:13pm | 813Charles River Laboratories (CRL) recently discussed its business outlook with investors and clarified its focus on four key initiatives to drive shareholder value. The company also announced 2011 guidance and made some changes to its 2010 outlook. The four key initiatives are as follows:...
-
Morning Market Movers (ITMN, BASI, NYMX, MI)
Friday, December 17, 2010 - 11:25am | 169InterMune Inc (NASDAQ: ITMN) jumped 101.89% to $28.81 at 10:24 am. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has backed the ITMN's experimental lung drug Esbriet. Bioanalytical Systems Inc (NASDAQ: BASI) climbed 40.00% to $2.52. BASI's shares...
-
Benzinga's Top Pre-Market NASDAQ Losers (CRDC, GPIC, VRSN, QGEN)
Thursday, December 16, 2010 - 10:03am | 150Cardica Inc (NASDAQ: CRDC) dipped 14.06% to $3.30 in the pre-market session. CRDC entered into a $10 million common stock financing agreement today, with Aspire Capital Fund. Gaming Partners International Corporation (NASDAQ: GPIC) lost 3.43% to $5.70 in the pre-market session. GPIC's quarterly-...
-
Benzinga's Top Downgrades (IRET, AEG, QGEN, RTN)
Thursday, December 16, 2010 - 9:21am | 145Investors Real Estate Trust (NASDAQ: IRET) was downgraded by Robert W Baird from "outperform" to "neutral." JKHY's stock closed at $9.02 yesterday. Investors Real Estate Trust's 52-week trading range is $7.79-$9.34 AEGON N V (NYSE: AEG) was downgraded by BofA/Merrill from "neutral" to "underperform...